ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Children and Health
This article is part of the Research TopicAllergies, Inflammation, and the Immune System: A Holistic Approach to Understanding the Interplay Between Host Microbiota and Chronic DiseasesView all articles
Analysis of Intestinal Microorganisms and Metabolite in Childhood Allergic Asthma: Role in Assessing the Severity of Condition in Children
Provisionally accepted
- Shenzhen University General Hospital, Shenzhen, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Childhood allergic asthma is a widespread chronic respiratory condition that is becoming more common worldwide. Presently, the evaluation of its severity depends on clinical symptoms and inflammatory indicators like neutrophils and CRP, which are not very specific. Increasing research indicates that the gut microbiota and its metabolites—such as Bifidobacterium, Lactobacillus, short-chain fatty acids, and lipopolysaccharides—are important in immune system regulation and might affect asthma severity through the gut–lung connection. This study aims to determine if these microbial and metabolic factors can be used as new biomarkers to assess the severity of allergic in children. Results: No significant differences in neutrophil/leukocyte counts, CRP, or Klebsiella prevalence were observed between the mild-moderate and severe-critical pediatric allergic asthma groups (P > 0.05). However, the mild-moderate group showed significantly higher levels of Bifidobacteria, Lactobacillus, acetic acid, propionic acid, and butyric acid, but lower Escherichia coli and lipopolysaccharide (LPS) than the severe-critical group (P < 0.05). Disease severity negatively correlated with Bifidobacteria, Lactobacillus, and these three short-chain fatty acids, and positively with E. coli and LPS (P < 0.05). For predicting severity, the area under the curve (AUC) was 0.686 for Bifidobacteria, 0.785 for Lactobacillus, 0.811 for E. coli, 0.711 for acetic acid, 0.653 for propionic acid, 0.788 for butyric acid, and 0.671 for LPS. Notably, a combined model integrating these markers achieved an AUC of 0.956, significantly outperforming any single predictor (P < 0.05). These results indicate that gut microbiota-derived metabolites hold substantial potential as biomarkers for assessing disease severity in children with allergic asthma. Conclusion: The composition of intestinal microbiota and their metabolites exhibits abnormal expression patterns in children diagnosed with allergic asthma, correlating with the severity of the disease. These alterations may serve as significant biomarkers for predicting the clinical severity in pediatric patients with allergic asthma.
Keywords: Childhood allergic asthma, Intestinal microorganisms, Metabolites, bifidobacteria, Lactobacillus
Received: 06 Aug 2025; Accepted: 17 Nov 2025.
Copyright: © 2025 Xu, Ma, Liu, Liang and Liao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Zhongnan Liao, liaozan1205@126.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.